These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1591693)
21. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells. Bonavida B; Katz J; Hoshino T Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275 [TBL] [Abstract][Full Text] [Related]
22. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes. Uchida A; Micksche M; Hoshino T Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269 [TBL] [Abstract][Full Text] [Related]
23. In vitro augmentation of natural killing activity by OK-432. Uchida A; Micksche M Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467 [TBL] [Abstract][Full Text] [Related]
24. Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro. Sakano S; Shimabukuro T; Ohmoto Y; Naito K Urol Res; 1997; 25(4):239-45. PubMed ID: 9286031 [TBL] [Abstract][Full Text] [Related]
25. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70. Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768 [TBL] [Abstract][Full Text] [Related]
26. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
27. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related]
28. Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells. Nio Y; Zighelboim J; Berek J; Bonavida B Cancer; 1989 Jul; 64(2):434-41. PubMed ID: 2736490 [TBL] [Abstract][Full Text] [Related]
29. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor. Uchida A; Moore M J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944 [TBL] [Abstract][Full Text] [Related]
30. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786 [TBL] [Abstract][Full Text] [Related]
31. Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma. Kagawa S; Ogura K; Kurokawa K; Uyama K J Urol; 1979 Oct; 122(4):467-70. PubMed ID: 480487 [TBL] [Abstract][Full Text] [Related]
32. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions. Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407 [TBL] [Abstract][Full Text] [Related]
33. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers. Satoh K; Kan N; Okino T; Mise K; Yamasaki S; Harada T; Hori T; Ohgaki K; Tobe T Biotherapy; 1993; 6(1):41-9. PubMed ID: 8507544 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion. Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900 [TBL] [Abstract][Full Text] [Related]
36. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines. Hermann GG; Zeuthen J; Claësson MH Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282 [TBL] [Abstract][Full Text] [Related]
37. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes. Wu XX; Zeng Y; Jin XH; Kakehi Y Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656 [TBL] [Abstract][Full Text] [Related]
38. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes]. Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612 [TBL] [Abstract][Full Text] [Related]
39. Bacillus Calmette-Guérin sensitises fresh transitional carcinoma cells and T24 cell line to non-MHC-restricted cytotoxicity in vitro. Kaasinen ES; Kalliomäki PH; Alfthan OS; Timonen TT Br J Urol; 1993 Dec; 72(6):897-906. PubMed ID: 8306153 [TBL] [Abstract][Full Text] [Related]
40. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions. Uchida A; Micksche M Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]